Page last updated: 2024-08-24

carbogen and Carcinoma in Situ

carbogen has been researched along with Carcinoma in Situ in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hoskin, P; Rojas, A; Saunders, M	1

Trials

1 trial(s) available for carbogen and Carcinoma in Situ

Article	Year
Accelerated radiotherapy, carbogen, and nicotinamide (ARCON) in the treatment of advanced bladder cancer: mature results of a Phase II nonrandomized study. International journal of radiation oncology, biology, physics, 2009, Apr-01, Volume: 73, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Carbon Dioxide; Carcinoma in Situ; Cystectomy; Dose Fractionation, Radiation; Feasibility Studies; Female; Humans; Male; Middle Aged; Neoplasm Staging; Niacinamide; Oxygen; Radiation-Sensitizing Agents; Remission Induction; Survival Rate; Urinary Bladder Neoplasms	2009

Article

Year

Accelerated radiotherapy, carbogen, and nicotinamide (ARCON) in the treatment of advanced bladder cancer: mature results of a Phase II nonrandomized study.

International journal of radiation oncology, biology, physics, 2009, Apr-01, Volume: 73, Issue:5

Topics: Adult; Aged; Aged, 80 and over; Carbon Dioxide; Carcinoma in Situ; Cystectomy; Dose Fractionation, Radiation; Feasibility Studies; Female; Humans; Male; Middle Aged; Neoplasm Staging; Niacinamide; Oxygen; Radiation-Sensitizing Agents; Remission Induction; Survival Rate; Urinary Bladder Neoplasms

2009